A096530 Stock Overview
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide.
Seegene, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₩32,200.00|
|52 Week High||₩83,900.00|
|52 Week Low||₩25,300.00|
|1 Month Change||10.65%|
|3 Month Change||4.38%|
|1 Year Change||-55.22%|
|3 Year Change||128.77%|
|5 Year Change||92.53%|
|Change since IPO||665.45%|
Recent News & Updates
Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?May 06
I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With EaseMar 15
Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?Feb 25
Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?Feb 08
What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?Jan 22
Calculating The Fair Value Of Seegene, Inc. (KOSDAQ:096530)Jan 07
Declining Stock and Solid Fundamentals: Is The Market Wrong About Seegene, Inc. (KOSDAQ:096530)?Dec 23
Can You Imagine How Elated Seegene's (KOSDAQ:096530) Shareholders Feel About Its 656% Share Price Gain?Dec 08
I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With EaseNov 24
Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?Jun 30
|A096530||KR Biotechs||KR Market|
Return vs Industry: A096530 underperformed the KR Biotechs industry which returned -40.8% over the past year.
Return vs Market: A096530 underperformed the KR Market which returned -19.7% over the past year.
|A096530 Average Weekly Movement||6.3%|
|Biotechs Industry Average Movement||8.1%|
|Market Average Movement||6.6%|
|10% most volatile stocks in KR Market||11.6%|
|10% least volatile stocks in KR Market||3.9%|
Stable Share Price: A096530 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: A096530's weekly volatility (6%) has been stable over the past year.
About the Company
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of six SNPs in factor II, factor V, and MTHFR genes; BRAF mutation characteristic for papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy, H&E slides, and paraffin-embedded tissues; Apolipoprotein E genotypes; and BCR/ABL fusion gene from blood and whole bone marrow.
Seegene, Inc. Fundamentals Summary
|A096530 fundamental statistics|
Is A096530 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A096530 income statement (TTM)|
|Cost of Revenue||₩418.99b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||6.81k|
|Net Profit Margin||30.09%|
How did A096530 perform over the long term?See historical performance and comparison